CREB fusion–associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype
Trecourt A, Macagno N, Ngo C, Philip CA, Lopez J, Ferreira J, Alves-Vale C, Ray-Coquard I, Genestie C, Agaimy A, Devouassoux-Shisheboran M (2023)
Publication Type: Journal article
Publication year: 2023
Journal
DOI: 10.1007/s00428-023-03546-1
Abstract
EWSR1/FUS-CREB-rearranged mesenchymal neoplasms are an emerging heterogeneous group of soft tissue tumors that encompasses low-grade lesions (angiomatoid fibrous histiocytoma/AFH) and a group of predominantly intra-abdominal aggressive sarcomas with epithelioid morphology and frequent keratin expression. Both entities occasionally harbor EWSR1::ATF1 fusions as alternate to the more frequent EWSR1/FUS::CREB1/CREM fusions. Although EWSR1/FUS-CREB-rearranged epithelioid malignant neoplasms have been described in diverse intra-abdominal sites, none involved the female adnexa. Herein, we describe three cases involving uterine adnexa in young females (41, 39, and 42-year-old); two associated with constitutional inflammatory symptoms. The tumors presented as a serosal surface mass of the ovary without parenchymal involvement (Case 1), as circumscribed nodule within ovarian parenchyma (Case 2), and as a periadnexal mass extending into the lateral uterine wall with lymph node metastasis (Case 3). They were composed of sheets and nests of large epithelioid cells with numerous stromal lymphocytes and plasma cells. The neoplastic cells expressed desmin and EMA, and variably WT1. One tumor expressed in addition AE1/AE3, MUC4, synaptophysin, chromogranin, and ALK. None expressed sex cord-associated markers. RNA sequencing identified EWSR1::ATF1 fusions in two cases and an EWSR1::CREM fusion in one. Exome-based RNA capture sequencing and clustering methods showed high transcriptomic proximity of tumor 1 with soft tissue AFH. This novel subset of female adnexal neoplasms should be included in the differential diagnosis of any epithelioid neoplasm involving female adnexa. Their aberrant immunophenotype can be misleading, underlining a wide spectrum of differential diagnosis.
Authors with CRIS profile
Additional Organisation(s)
Involved external institutions
Instituto Português de Oncologia Francisco Gentil (IPO) / Portuguese Oncology Institute
Portugal (PT)
Université Claude Bernard Lyon 1 (UCB)
France (FR)
Marseille Medical Genetics (MMG)
France (FR)
Institut Gustave-Roussy
France (FR)
Croix-Rousse hospital / Hôpital de la Croix-Rousse
France (FR)
Hospices Civils de Lyon (CHU)
France (FR)
CUF Porto Hospital
Portugal (PT)
Portugal (PT)
Université Claude Bernard Lyon 1 (UCB)
France (FR)
Marseille Medical Genetics (MMG)
France (FR)
Institut Gustave-Roussy
France (FR)
Croix-Rousse hospital / Hôpital de la Croix-Rousse
France (FR)
Hospices Civils de Lyon (CHU)
France (FR)
CUF Porto Hospital
Portugal (PT)
How to cite
APA:
Trecourt, A., Macagno, N., Ngo, C., Philip, C.A., Lopez, J., Ferreira, J.,... Devouassoux-Shisheboran, M. (2023). CREB fusion–associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype. Virchows Archiv. https://doi.org/10.1007/s00428-023-03546-1
MLA:
Trecourt, Alexis, et al. "CREB fusion–associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype." Virchows Archiv (2023).
BibTeX: Download